PlainRecalls
FDA Drug Critical Class I Terminated

0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

Reported: September 24, 2014 Initiated: July 11, 2014 #D-1591-2014

Product Description

0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

Reason for Recall

Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.

Details

Recalling Firm
Baxter Healthcare Corp.
Units Affected
a) 217,536 bags; b) 161,760 bags
Distribution
Nationwide, Puerto Rico, Singapore, and Hong Kong
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
0.9% Sodium Chloride Injection USP, packaged in a) 50 mL VIAFLEX Container bags, NDC 0338-0049-41, Product Code 2B1306; and b) 100 mL VIAFLEX Container bags, NDC 0338-0049-18, Product Code 2B1302, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.. Recalled by Baxter Healthcare Corp.. Units affected: a) 217,536 bags; b) 161,760 bags.
Why was this product recalled?
Presence of Particulate Matter: particulate matter identified as fibers and/or plastics.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 24, 2014. Severity: Critical. Recall number: D-1591-2014.